LABU.US Direxion Daily S&P Biotech Bull 3X Shares

- USD
No recent price
Total assets
540M
Expense ratio
0.91%
Dividend yield
0.38%
1-year return
+61.27%
Holdings
157
Since
2015

Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.

What does LABU.US invest in?

  • Mostly Other (76.6%)
  • Largest sector: Healthcare (98.4%)
  • Largest region: North America (98.7%)
  • Top 3 holdings: 1.3% of the fund

Asset allocation

  • Other 76.6%
  • US stocks 20.2%
  • Cash 1.4%
  • Non-US stocks 0.7%

Top holdings

  • Moderna Inc 0.56%
  • TG Therapeutics Inc 0.39%
  • Biogen Inc 0.39%
  • AbbVie Inc 0.38%
  • United Therapeutics Corporation 0.38%
All holdings, sectors and regions

Direxion Daily S&P Biotech Bull 3X Shares performance

Sharpe ratio 0.96
This year
+37.46%
1 year
+61.27%
3 years
+58.57%
5 years
-28.47%

Volatility 68.7% over 1 year and 76.2% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

LABU.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About Direxion Daily S&P Biotech Bull 3X Shares

The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.

Full fund profile